Articles in this section

• Global State of Harm Reduction 2020

  

  Harm Reduction International released the 7th edition of the annual Global State of Harm Reduction report, based on one year of data collection. COVID-19 disrupted everything and this monumental report monitors harm reduction services on the ground, where possible, and how people who use drugs have been impacted. More

  13 February 2021

• Access to Hepatitis C Treatment and Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected Issue brief

  

  Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans. An issue brief, developed by Treatment Action Group (TAG) and Médecins du Monde (MdM) based on crowdsourced hepatitis C data, aims to provide supplemental evidence for advocates on hepatitis C treatment uptake and care among people who inject drugs, which could help inform national and regional campaigns. More

  2 February 2020

• Who Has Access to Hepatitis C Testing? Liberate Our Diagnostics! Issue brief

  

  Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up testing services and linking people to treatment and care, as part of implementing their national hepatitis plans. An issue brief, developed by Treatment Action Group (TAG) and Médecins du Monde (MdM) based on crowdsourced hepatitis C data, aims to provide supplemental evidence for advocates on hepatitis C diagnostics availability and pricing, which could help inform national and regional campaigns. More

  24 January 2020

• A 6 Fact Rendezvous with Hepatitis C General overview of the silent epidemic

  

  Currently, there are an estimated 80 million people living with chronic hepatitis C globally and millions are newly infected every year. The World Health Organization attributes an estimated 700,000 deaths to hepatitis C. More

  3 March 2017